467 related articles for article (PubMed ID: 10346939)
21. Synthesis of novel purine nucleosides towards a selective inhibition of human butyrylcholinesterase.
Marcelo F; Silva FV; Goulart M; Justino J; Sinaÿ P; Blériot Y; Rauter AP
Bioorg Med Chem; 2009 Jul; 17(14):5106-16. PubMed ID: 19520578
[TBL] [Abstract][Full Text] [Related]
22. Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease.
Melchiorre C; Andrisano V; Bolognesi ML; Budriesi R; Cavalli A; Cavrini V; Rosini M; Tumiatti V; Recanatini M
J Med Chem; 1998 Oct; 41(22):4186-9. PubMed ID: 9784091
[No Abstract] [Full Text] [Related]
23. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
[TBL] [Abstract][Full Text] [Related]
24. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
[TBL] [Abstract][Full Text] [Related]
25. Phenserine Axonyx.
Thatte U
Curr Opin Investig Drugs; 2005 Jul; 6(7):729-39. PubMed ID: 16044670
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of butyrylcholinesterase by singlet oxygen-generated melatonin derivatives.
Moleda Z; Wojtasiewicz K; Panasiewicz M; Czarnocki Z
J Pineal Res; 2010 Aug; 49(1):55-9. PubMed ID: 20459459
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
Utku S; Gökçe M; Orhan I; Sahin MF
Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
[TBL] [Abstract][Full Text] [Related]
30. Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine.
Darvesh S; McDonald RS; Darvesh KV; Mataija D; Conrad S; Gomez G; Walsh R; Martin E
Bioorg Med Chem; 2007 Oct; 15(19):6367-78. PubMed ID: 17681768
[TBL] [Abstract][Full Text] [Related]
31. Tacrine based human cholinesterase inhibitors: synthesis of peptidic-tethered derivatives and their effect on potency and selectivity.
Butini S; Guarino E; Campiani G; Brindisi M; Coccone SS; Fiorini I; Novellino E; Belinskaya T; Saxena A; Gemma S
Bioorg Med Chem Lett; 2008 Oct; 18(19):5213-6. PubMed ID: 18786825
[TBL] [Abstract][Full Text] [Related]
32. New tacrine-hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest for the early diagnostics of Alzheimer's disease.
Szymański P; Zurek E; Mikiciuk-Olasik E
Pharmazie; 2006 Apr; 61(4):269-73. PubMed ID: 16649535
[TBL] [Abstract][Full Text] [Related]
33. Ligand-based 3D-QSAR studies of physostigmine analogues as acetylcholinesterase inhibitors.
Ul-Haq Z; Mahmood U; Jehangir B
Chem Biol Drug Des; 2009 Dec; 74(6):571-81. PubMed ID: 19843075
[TBL] [Abstract][Full Text] [Related]
34. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase.
Catto M; Pisani L; Leonetti F; Nicolotti O; Pesce P; Stefanachi A; Cellamare S; Carotti A
Bioorg Med Chem; 2013 Jan; 21(1):146-52. PubMed ID: 23199476
[TBL] [Abstract][Full Text] [Related]
36. Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors.
Campiani G; Fattorusso C; Butini S; Gaeta A; Agnusdei M; Gemma S; Persico M; Catalanotti B; Savini L; Nacci V; Novellino E; Holloway HW; Greig NH; Belinskaya T; Fedorko JM; Saxena A
J Med Chem; 2005 Mar; 48(6):1919-29. PubMed ID: 15771436
[TBL] [Abstract][Full Text] [Related]
37. Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases.
Atack JR; Yu QS; Soncrant TT; Brossi A; Rapoport SI
J Pharmacol Exp Ther; 1989 Apr; 249(1):194-202. PubMed ID: 2709330
[TBL] [Abstract][Full Text] [Related]
38. 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
Vitorović-Todorović MD; Juranić IO; Mandić LM; Drakulić BJ
Bioorg Med Chem; 2010 Feb; 18(3):1181-93. PubMed ID: 20061157
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological activity of pyridinium-type acetylcholinesterase inhibitors.
Alptüzün V; Kapková P; Baumann K; Erciyas E; Holzgrabe U
J Pharm Pharmacol; 2003 Oct; 55(10):1397-404. PubMed ID: 14607022
[TBL] [Abstract][Full Text] [Related]
40. Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.
Carolan CG; Dillon GP; Gaynor JM; Reidy S; Ryder SA; Khan D; Marquez JF; Gilmer JF
J Med Chem; 2008 Oct; 51(20):6400-9. PubMed ID: 18817366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]